[HTML][HTML] Clinical use of thrombin generation assays

NB Binder, F Depasse, J Mueller, T Wissel… - Journal of Thrombosis …, 2021 - Elsevier
Determining patient's coagulation profile, ie detecting a bleeding tendency or the opposite, a
thrombotic risk, is crucial for clinicians in many situations. Routine coagulation assays and …

Thrombin: a pivotal player in hemostasis and beyond

JB Larsen, AM Hvas - Seminars in Thrombosis and Hemostasis, 2021 - thieme-connect.com
The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by
converting fibrinogen to fibrin and activating coagulation factor XIII whereby the fibrin clot is …

Thrombin generation in patients with COVID-19 with and without thromboprophylaxis

E Campello, C Bulato, L Spiezia, A Boscolo… - Clinical Chemistry and …, 2021 - degruyter.com
Objectives Thrombin generation (TG) with and without thrombomodulin (TM) was evaluated
in COVID-19 patients with different disease severity and thromboprophylaxis regimen, in …

Mean platelet volume predicts severe COVID-19 illness

G Lippi, BM Henry, EJ Favaloro - Seminars in thrombosis and …, 2021 - thieme-connect.com
The parameter mean platelet volume (MPV) is a simple and relatively inexpensive
laboratory measure that reliably reflects platelet size. Evidence has been provided that …

Involvement of inflammation in venous thromboembolic disease: an update in the age of COVID-19

P Poredos, P Poredos - Seminars in thrombosis and …, 2022 - thieme-connect.com
The inflammatory process is strongly involved in the pathophysiology of venous
thromboembolism (VTE) and has a significant role in disease prediction. Inflammation most …

Parameters and morphological changes of erythrocytes and platelets of COVID-19 subjects: a longitudinal cohort study

L Shen, L Chen, H Chi, L Luo, J Ruan… - Infection and Drug …, 2023 - Taylor & Francis
Purpose Information about dynamic changes occurring in the parameters and morphology of
erythrocytes and platelets during the coronavirus disease 2019 (COVID-19) infection and …

Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): part II

EJ Favaloro, G Lippi - Seminars in Thrombosis and Hemostasis, 2021 - thieme-connect.com
Welcome to another issue of Seminars in Thrombosis and Hemostasis (STH). This issue is
published under the “banner” of “Maintaining hemostasis and preventing thrombosis in …

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort

TW van de Berg, MMG Mulder, T Alnima… - Frontiers in …, 2022 - frontiersin.org
Background COVID-19 associated coagulopathy (CAC) is associated with an increase in
thromboembolic events. Current guidelines recommend prophylactic heparins in the …

[HTML][HTML] Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients

J Goswami, TA MacArthur, M Sridharan, J Tange… - Thrombosis …, 2021 - Elsevier
Background COVID-19-associated coagulopathy is incompletely understood. Objectives To
characterize thrombin generation, Von Willebrand Factor (VWF), neutrophil extracellular …

Лабораторные параметры системы гемостаза у пациентов с COVID-19

ЕА Серёгина, ЕМ Кольцова… - … и иммунопатологии в …, 2021 - hemoncim.com
Аннотация Новая коронавирусная инфекция (в настоящее время классифицируемая
как COVID-19), впервые выявленная в декабре 2019 г. в Ухане (Китайская Народная …